Drug Profile
HSP Gp96 vaccine - Cure and Sure Biotech
Alternative Names: Autologous Gp96 vaccine - Cure & Sure Biotech; Autologous heat shock protein Gp96 vaccine - Cure & Sure Biotech; Autologous tumour derived HSP Gp96 vaccine - Cure & Sure Biotech; HSP Gp96 vaccine - Cure & Sure Biotech; HSPPC-96 - Cure & Sure BiotechLatest Information Update: 25 Jul 2022
Price :
$50
*
At a glance
- Originator Cure&Sure Biotech
- Developer Chinese Academy of Medical Sciences; Chinese PLA General Hospital; Cure&Sure Biotech
- Class Cancer vaccines; Protein vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Glioblastoma
- Phase I/II Gastric cancer; Liver cancer; Pancreatic cancer
Most Recent Events
- 25 Jul 2022 Phase-II development in Glioblastoma (Adjuvant therapy) is ongoing in China (SC) (NCT03650257)
- 19 Dec 2019 Cure and Sure Biotech plans a phase II/III trial for Liver cancer (SC) (NCT04206254)
- 28 Mar 2019 No recent reports of development identified for phase-I development in Glioblastoma in China (SC)